What is Targeted Medical?
, a specialty pharmaceutical company, doing business as Physician Therapeutics, develops and commercializes amino acid based medications to physicians, pharmacies, and patients in the United States.
TRGM · Verdict
Limited reward · elevated risk
TRGM stands out on volatility and valuation, but watch the balance sheet signal.
Based on 88% data coverage
TRGM · Verdict
Above average
Above average
Current ratio 0.06
Rev -10.3% CAGR · earnings -31.8%
-24% free-cash-flow margin
-58% net margin · 0% ROE
Model-based scoring. For information only — not financial advice.
, a specialty pharmaceutical company, doing business as Physician Therapeutics, develops and commercializes amino acid based medications to physicians, pharmacies, and patients in the United States. It offers a line of patented amino acid based medical food products, dietary supplements, and generic drugs primarily for the treatment of metabolic syndrome/obesity; sleep disorders associated with anxiety; hypertension; viral infections; cognitive disorders/fatigue; sleep disorders associated with depression, fibromyalgia, and PTSD; pain disorders and inflammatory conditions/fibromyalgia; osteoarthritis and joint disorders; and peripheral neuropathy. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 3.02K.
The scoring profile indicates weak reward characteristics across most factors, including valuation and momentum. Risk indicators are elevated — volatility and macro sensitivity warrant consideration.
For informational purposes only. Not financial advice.